Area of research
Biomedical Engineering · Biomaterials
Research interest
Research interests include Tumor microenvironment, Cancer research, Medicine, Drug delivery, Immune system, and Chemistry.
Engineered Bacterial Outer Membrane Vesicles‐Based Doxorubicin and CD47‐siRNA Co‐Delivery Nanoplatform Overcomes Immune Resistance to Potentiate the Immunotherapy of Glioblastoma
Transcytosis-Triggering Nanoparticles for Overcoming Stromal Barriers and Reversing Immunosuppression in Pancreatic Cancer Combinatorial Therapy
DNase I‐Mediated Chemotactic Nanoparticles for NETs Targeting and Microenvironment Remodeling Treatment of Acute Ischemic Stroke
PROTAC-loaded nanocapsules degrading BRD4 for radio-chemotherapy sensitization in glioblastoma
Manganese-based virus-mimicking nanomedicine with triple immunomodulatory functions inhibits breast cancer brain metastasis
Mitocytosis-inducing nanoparticles alleviate gemcitabine resistance via dual disruption of pyrimidine synthesis and redox homeostasis in pancreatic ductal adenocarcinoma
A Peptide‐Drug Conjugate‐Based Nanoplatform for Immunometabolic Activation and In Situ Nerve Regeneration in Advanced‐Stage Alzheimer's Disease
Recent advances in biomimetic strategies for the immunotherapy of glioblastoma
PROTAC delivery in tumor immunotherapy: Where are we and where are we going?
Reconciling the Cooperative–Competitive Patterns among Tumor and Immune Cells for Triple‐Negative Breast Cancer Treatment Using Multimodule Nanocomplexes
Stimuli-responsive drug delivery systems triggered by intracellular or subcellular microenvironments
Pleiotropic Microenvironment Remodeling Micelles for Cerebral Ischemia-Reperfusion Injury Therapy by Inhibiting Neuronal Ferroptosis and Glial Overactivation
ROS/Electro Dual-Reactive Nanogel for Targeting Epileptic Foci to Remodel Aberrant Circuits and Inflammatory Microenvironment
Transcytosis Mediated Deep Tumor Penetration for Enhanced Chemotherapy and Immune Activation of Pancreatic Cancer
Intelligent Delivery Systems in Tumor Metabolism Regulation: Exploring the Path Ahead
A Triple Therapeutic Strategy with Antiexosomal Iron Efflux for Enhanced Ferroptosis Therapy and Immunotherapy
A neutrophil-biomimic platform for eradicating metastatic breast cancer stem-like cells by redox microenvironment modulation and hypoxia-triggered differentiation therapy
Brain‐targeting drug delivery systems
ROS-removing nano-medicine for navigating inflammatory microenvironment to enhance anti-epileptic therapy
Emerging landscapes of nanosystems based on pre-metastatic microenvironment for cancer theranostics
Macrophage‐Disguised Manganese Dioxide Nanoparticles for Neuroprotection by Reducing Oxidative Stress and Modulating Inflammatory Microenvironment in Acute Ischemic Stroke
Sequentially Triggered Bacterial Outer Membrane Vesicles for Macrophage Metabolism Modulation and Tumor Metastasis Suppression
Biomimetic Dendrimer–Peptide Conjugates for Early Multi‐Target Therapy of Alzheimer's Disease by Inflammatory Microenvironment Modulation
Exosomes derived from immunogenically dying tumor cells as a versatile tool for vaccination against pancreatic cancer
Intravenous route to choroidal neovascularization by macrophage-disguised nanocarriers for mTOR modulation
Evolution of blood–brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies
Recent advances in nanomedicines for the treatment of ischemic stroke
Penetrable Nanoplatform for “Cold” Tumor Immune Microenvironment Reeducation
Co-delivery of Cu(I) chelator and chemotherapeutics as a new strategy for tumor theranostic
Microthrombus‐Targeting Micelles for Neurovascular Remodeling and Enhanced Microcirculatory Perfusion in Acute Ischemic Stroke